Literature DB >> 15654817

Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis.

Lin Chen1, O Martinez, P Venkataramani, S-X Lin, B S Prabhakar, L S Chan.   

Abstract

Atopic dermatitis is a chronic inflammatory skin disease characterized by inflammatory cell infiltration in the skin. In order to assess the roles of inflammatory cells in this disease, we analysed the activation status and surface markers of various leucocytes in the IL-4 transgenic mouse model of atopic dermatitis, by flow cytometry, immuofluorescence microscopy, and T cell proliferation assays. The studies were performed with a nontransgenic mouse control and transgenic mice at three disease stages: before disease onset, early skin disease, and late skin disease, so that we can delineate the immunological sequence of events. As the skin disease evolves, the skin draining lymph node cells from IL-4-Tg mice show a spontaneous proliferation and a progressively enhanced proliferative response to stimulants including anti-CD3, Con A, PHA, and Staphylococcus enterotoxins A and B. As the disease evolves, the percent of lymphoid organ T cells expressing activation molecules (CD44 and CD69) and costimulatory molecules (ICOS and PD-1) are progressively increased; the percent and total number of T cells are reduced in an incremental manner in the secondary lymphoid organs while the number of T cells infiltrating the skin increases in an incremental fashion; the total number of dendritic antigen presenting cells, macrophages, and NK cells gradually increases in the lymphoid organs. Collectively, our results suggest that there is a continued and progressive migration of activated inflammatory cells from the secondary lymphoid organs into the skin where they participate in immune responses resulting in the pathology associated with inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654817      PMCID: PMC1809278          DOI: 10.1111/j.1365-2249.2004.02691.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  The expanding world of co-stimulation: the two-signal model revisited.

Authors:  C A Chambers
Journal:  Trends Immunol       Date:  2001-04       Impact factor: 16.687

2.  ICOS is critical for CD40-mediated antibody class switching.

Authors:  A J McAdam; R J Greenwald; M A Levin; T Chernova; N Malenkovich; V Ling; G J Freeman; A H Sharpe
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

Review 3.  A crucial role for CD44 in inflammation.

Authors:  E Puré; C A Cuff
Journal:  Trends Mol Med       Date:  2001-05       Impact factor: 11.951

4.  ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses.

Authors:  J A Gonzalo; J Tian; T Delaney; J Corcoran; J B Rottman; J Lora; A Al-garawi; R Kroczek; J C Gutierrez-Ramos; A J Coyle
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

Review 5.  The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

Authors:  Beatriz M Carreno; Mary Collins
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis.

Authors:  L S Chan; N Robinson; L Xu
Journal:  J Invest Dermatol       Date:  2001-10       Impact factor: 8.551

Review 7.  CD44 cell adhesion molecules.

Authors:  S Goodison; V Urquidi; D Tarin
Journal:  Mol Pathol       Date:  1999-08

8.  Atopic dermatitis: immunophenotyping of inflammatory cells in skin lesions.

Authors:  L Lugović; J Lipozenocić; J Jakić-Razumović
Journal:  Int J Dermatol       Date:  2001-08       Impact factor: 2.736

9.  An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis.

Authors:  A L Woodward; J M Spergel; H Alenius; E Mizoguchi; A K Bhan; E Castigli; S R Brodeur; H C Oettgen; R S Geha
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

10.  B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.

Authors:  S Y Tseng; M Otsuji; K Gorski; X Huang; J E Slansky; S I Pai; A Shalabi; T Shin; D M Pardoll; H Tsuchiya
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

View more
  6 in total

1.  Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.

Authors:  Mao-Qiang Man; Yutaka Hatano; Seung H Lee; Mona Man; Sandra Chang; Kenneth R Feingold; Donald Y M Leung; Walter Holleran; Yoshikazu Uchida; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-08-02       Impact factor: 8.551

Review 2.  Lessons from murine models of atopic dermatitis.

Authors:  Tao Zheng; Zhou Zhu
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.806

3.  The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE.

Authors:  L Chen; S-X Lin; L Overbergh; C Mathieu; L S Chan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic Dermatitis.

Authors:  Yan Zhao; Lei Bao; Lawrence S Chan; Luisa A DiPietro; Lin Chen
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 5.  Translational Animal Models of Atopic Dermatitis for Preclinical Studies.

Authors:  Britta C Martel; Paola Lovato; Wolfgang Bäumer; Thierry Olivry
Journal:  Yale J Biol Med       Date:  2017-09-25

6.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.